These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10206861)

  • 21. Comment: syncopal episodes associated with cisapride.
    Trinkle R
    Ann Pharmacother; 1999 Feb; 33(2):251. PubMed ID: 10084425
    [No Abstract]   [Full Text] [Related]  

  • 22. Prolongation of the QT interval related to cisapride-diltiazem interaction.
    Thomas AR; Chan LN; Bauman JL; Olopade CO
    Pharmacotherapy; 1998; 18(2):381-5. PubMed ID: 9545159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long QT syndrome during high-dose cisapride.
    Bran S; Murray WA; Hirsch IB; Palmer JP
    Arch Intern Med; 1995 Apr; 155(7):765-8. PubMed ID: 7695465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cisapride high dosage and long QT interval.
    Bedu A; Lupoglazoff JM; Faure C; Denjoy I; Casasoprana A; Aujard Y
    J Pediatr; 1997 Jan; 130(1):164. PubMed ID: 9003872
    [No Abstract]   [Full Text] [Related]  

  • 25. CNS adverse effects of cisapride in children.
    Torringa ML; van Roon EN; de Vries TW
    Ann Pharmacother; 2003 Sep; 37(9):1344. PubMed ID: 12921525
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of cisapride on ventricular repolarization in children.
    Tutar HE; Kansu A; Kalayci AG; Girgin N; Atalay S; Imamoğlu A
    Acta Paediatr; 2000 Jul; 89(7):820-3. PubMed ID: 10943965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New safety recommendations for use of cisapride (Propulsid).
    Harv Heart Lett; 2000 Apr; 10(8):7. PubMed ID: 10712753
    [No Abstract]   [Full Text] [Related]  

  • 28. Role of cisapride in preterm infants.
    Craig JS; McClure BG; Tubman TR
    Arch Dis Child Fetal Neonatal Ed; 1999 May; 80(3):F253. PubMed ID: 10744431
    [No Abstract]   [Full Text] [Related]  

  • 29. Domperidone versus cisapride in the treatment of infant regurgitation and increased acid gastro-oesophageal reflux: a pilot study.
    Hegar B; Alatas S; Advani N; Firmansyah A; Vandenplas Y
    Acta Paediatr; 2009 Apr; 98(4):750-5. PubMed ID: 19076984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of cisapride on ventricular depolarization-repolarization and arrhythmia markers in infants.
    Zamora SA; Belli DC; Ferrazzini G; Friedli B
    Biol Neonate; 2001 Jul; 80(1):30-4. PubMed ID: 11474146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Long QT interval and malignant ventricular arrhythmia during treatment with cisapride. Report of a clinical case].
    Massari FM; Trevano FQ; Diehl L; Romano S
    Ital Heart J Suppl; 2000 Aug; 1(8):1055-8. PubMed ID: 10993015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of cisapride on the QT interval in infants with gastroesophageal reflux.
    Khoshoo V; Edell D; Clarke R
    Pediatrics; 2000 Feb; 105(2):E24. PubMed ID: 10654984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spontaneous adverse event reports of serious ventricular arrhythmias, QT prolongation, syncope, and sudden death in patients treated with cisapride.
    Barbey JT; Lazzara R; Zipes DP
    J Cardiovasc Pharmacol Ther; 2002 Apr; 7(2):65-76. PubMed ID: 12075394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Long QT syndrome under cisapride in neonates and infants].
    Lupoglazoff JM; Bedu A; Faure C; Denjoy I; Casasoprana A; Cézard JP; Aujard Y
    Arch Pediatr; 1997 Jun; 4(6):509-14. PubMed ID: 9239264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Possible interaction between cisapride and digoxin.
    Kubler PA; Pillans PI; McKay JR
    Ann Pharmacother; 2001 Jan; 35(1):127-8. PubMed ID: 11197577
    [No Abstract]   [Full Text] [Related]  

  • 36. Does cisapride influence cardiac rhythm? Results of a United States multicenter, double-blind, placebo-controlled pediatric study.
    Levy J; Hayes C; Kern J; Harris J; Flores A; Hyams J; Murray R; Tolia V
    J Pediatr Gastroenterol Nutr; 2001 Apr; 32(4):458-63. PubMed ID: 11396814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age-related differences in the direct cardiac effects of cisapride: narrower safety range in the hearts of young rabbits.
    Wu MH; Su MJ; Sun SS
    Pediatr Res; 2003 Mar; 53(3):493-9. PubMed ID: 12595600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of cisapride on the corrected QT interval and QT dispersion in premature infants.
    Cools F; Benatar A; Bougatef A; Vandenplas Y
    J Pediatr Gastroenterol Nutr; 2001 Aug; 33(2):178-81. PubMed ID: 11568520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prokinetic agents and QT prolongation: a familiar scene with new actors.
    Keller GA; Di Girolamo G
    Curr Drug Saf; 2010 Jan; 5(1):73-8. PubMed ID: 20210722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cisapride-induced prolonged QT interval: too much of a good thing!
    Hanson R; Browne G; Fasher B; Mcaskill M; Moroney P; Hawker R
    J Pediatr; 1997 Jan; 130(1):164-6. PubMed ID: 9003873
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.